These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 10942188
21. The plasma pharmacokinetics and cerebral spinal fluid penetration of intravenous topiramate in newborn pigs. Galinkin JL, Kurth CD, Shi H, Priestley MA, Loepke AW, Adamson PC. Biopharm Drug Dispos; 2004 Sep; 25(6):265-71. PubMed ID: 15334626 [Abstract] [Full Text] [Related]
22. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease. Smith PF, Petros WP, Soucie MP, Copeland KR. Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140 [Abstract] [Full Text] [Related]
23. Rapid approach to the quantitative determination of topiramate (2, 3:4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. Chen S, Carvey PM. Rapid Commun Mass Spectrom; 1999 Apr; 13(20):1980-4. PubMed ID: 10510408 [Abstract] [Full Text] [Related]
24. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net. White LO, Holt HA, Reeves DS, MacGowan AP. J Antimicrob Chemother; 1997 Mar; 39(3):355-61. PubMed ID: 9096185 [Abstract] [Full Text] [Related]
25. Lack of an effect of topiramate on lamotrigine serum concentrations. Berry DJ, Besag FM, Pool F, Natarajan J, Doose D. Epilepsia; 2002 Aug; 43(8):818-23. PubMed ID: 12180999 [Abstract] [Full Text] [Related]
26. Comparison of fluorescence polarization immunoassay and high performance liquid chromatography for determination of carbamazepine concentration in blood of poisoned patients. Wilimowska J, Gomółlka E, Pasich A, Jenner B, Szpak D. Przegl Lek; 2005 Aug; 62(6):595-8. PubMed ID: 16225132 [Abstract] [Full Text] [Related]
27. A capillary gas chromatographic assay with nitrogen phosphorus detection for the quantification of topiramate in human plasma, urine and whole blood. Riffitts JM, Gisclon LG, Stubbs RJ, Palmer ME. J Pharm Biomed Anal; 1999 Mar; 19(3-4):363-71. PubMed ID: 10704102 [Abstract] [Full Text] [Related]
28. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Rosenfeld WE, Doose DR, Walker SA, Nayak RK. Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594 [Abstract] [Full Text] [Related]
29. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C, Baftiu A, Tysse I, Valsø B, Larsson PG, Rytter E, Johannessen SI. Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [Abstract] [Full Text] [Related]
30. Simple and sensitive high performance liquid chromatography method with fluorescence detection for therapeutic drug monitoring of topiramate. Milosheska D, Vovk T, Grabnar I, Roškar R. Acta Chim Slov; 2015 Aug; 62(2):411-9. PubMed ID: 26085425 [Abstract] [Full Text] [Related]
31. Clinical experience with topiramate dosing and serum levels in patients with epilepsy. Zanotta N, Raggi ME, Radice L, Degrate A, Bresolin N, Zucca C. Seizure; 2006 Mar; 15(2):86-92. PubMed ID: 16406695 [Abstract] [Full Text] [Related]
32. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy. Rosenfeld WE, Liao S, Kramer LD, Anderson G, Palmer M, Levy RH, Nayak RK. Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595 [Abstract] [Full Text] [Related]
33. Restricted-access media high pressure liquid chromatography vs fluorescence polarization immunoassay for analysis of carbamazepine in human plasma. Ma J, Zhu PL, Xie JW, Jia ZP, Yang JS. Acta Pharmacol Sin; 2002 Jan; 23(1):87-91. PubMed ID: 11860744 [Abstract] [Full Text] [Related]
34. Topiramate in refractory epilepsy: a prospective observational study. Stephen LJ, Sills GJ, Brodie MJ. Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624 [Abstract] [Full Text] [Related]
35. Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma. Chen S, Carvey P. Rapid Commun Mass Spectrom; 2001 Aug; 15(2):159-63. PubMed ID: 11180545 [Abstract] [Full Text] [Related]
36. Impact of topiramate on serum bicarbonate concentrations in adults. Garris SS, Oles KS. Ann Pharmacother; 2005 Mar; 39(3):424-6. PubMed ID: 15701764 [Abstract] [Full Text] [Related]
37. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring. Aumente MD, López-Santamaría J, Donoso-Rengifo MC, Reyes-Torres I, Montejano Hervás P. Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926 [Abstract] [Full Text] [Related]
38. Factors influencing serum topiramate concentrations in routine therapeutic drug monitoring in Korean adult patients with epilepsy. Huh HJ, Joo EY, Hong SB, Ahn JH, Seo DW, Lee SY. Ther Drug Monit; 2013 Apr; 35(2):177-82. PubMed ID: 23503443 [Abstract] [Full Text] [Related]
40. The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate. Gidal BE, Clark AM, Anders B, Gilliam F. Epilepsy Res; 2017 Jan; 129():26-32. PubMed ID: 27883934 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]